ATE411023T1 - Zusammensetzung von artenusat und mefloquin zur behandlung von malaria - Google Patents

Zusammensetzung von artenusat und mefloquin zur behandlung von malaria

Info

Publication number
ATE411023T1
ATE411023T1 AT02711864T AT02711864T ATE411023T1 AT E411023 T1 ATE411023 T1 AT E411023T1 AT 02711864 T AT02711864 T AT 02711864T AT 02711864 T AT02711864 T AT 02711864T AT E411023 T1 ATE411023 T1 AT E411023T1
Authority
AT
Austria
Prior art keywords
malaria
mefloquine
treatment
combination
artesunate
Prior art date
Application number
AT02711864T
Other languages
English (en)
Inventor
Edgar Mueller
Max Scheiwe
Original Assignee
Mepha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mepha Ltd filed Critical Mepha Ltd
Application granted granted Critical
Publication of ATE411023T1 publication Critical patent/ATE411023T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02711864T 2002-02-13 2002-02-13 Zusammensetzung von artenusat und mefloquin zur behandlung von malaria ATE411023T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2002/001500 WO2003075927A1 (en) 2002-02-13 2002-02-13 Pharmaceutical combination of artesunate and mefloquine for therapy of malaria

Publications (1)

Publication Number Publication Date
ATE411023T1 true ATE411023T1 (de) 2008-10-15

Family

ID=27798743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02711864T ATE411023T1 (de) 2002-02-13 2002-02-13 Zusammensetzung von artenusat und mefloquin zur behandlung von malaria

Country Status (7)

Country Link
US (1) US20050148628A1 (de)
EP (1) EP1476160B1 (de)
AT (1) ATE411023T1 (de)
DE (1) DE60229440D1 (de)
DK (1) DK1476160T3 (de)
ES (1) ES2312553T3 (de)
WO (1) WO2003075927A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0413767A (pt) * 2003-09-04 2006-10-31 Cipla Ltd produto farmacêutico ou formulação farmacêutica, processo para preparar um produto farmacêutico ou formulação farmacêutica, método para tratar um doença e uso de pelo menos uma artemisinina ou um sal, solvato ou derivado desta
CH700941B1 (de) * 2007-12-04 2010-11-15 Mepha Ag Pharmazeutische Zusammensetzung zur Behandlung von Malaria.
EP2770985A4 (de) 2011-10-25 2015-01-21 U S Phytotherapy Inc Artemisinin- und berberinzusammensetzungen sowie verfahren zu ihrer herstellung
US9358261B2 (en) 2011-10-25 2016-06-07 U.S. Phytotherapy, Inc. Additional artemisinin and berberine compositions and methods of making
US9675582B2 (en) 2011-10-25 2017-06-13 U.S. Phytotherapy, Inc. Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
WO2013082469A2 (en) * 2011-12-02 2013-06-06 University Of Vermont And State Agricultural College Methods and compositions for treating infections
WO2022123323A1 (en) * 2020-12-09 2022-06-16 Menschlich Healthcare (Opc) Private Limited A pharmaceutical composition of artesunate and mefloquine and method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68906345T2 (de) * 1988-10-07 1993-10-28 Hoechst Ag Antimalariazusammenstellungen, gebrauchmachend von Quinidin, Artemisinin und ihren Derivaten.
US4998623A (en) * 1990-04-27 1991-03-12 Omni Medical Systems Inc. Medication dispensing package
US6326023B1 (en) * 2000-03-28 2001-12-04 Council Of Scientific & Industrial Research Synergistic anti-malarial formulation

Also Published As

Publication number Publication date
EP1476160B1 (de) 2008-10-15
WO2003075927A1 (en) 2003-09-18
DE60229440D1 (de) 2008-11-27
ES2312553T3 (es) 2009-03-01
DK1476160T3 (da) 2009-01-26
US20050148628A1 (en) 2005-07-07
EP1476160A1 (de) 2004-11-17

Similar Documents

Publication Publication Date Title
DE60321929D1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
TR200500745T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
DE60118547D1 (de) Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält
DE69834268D1 (de) Peroral zu verabreichende arzneiform enthaltend eine kombination von einem opioid agonisten und naltrexon
HUP0004300A2 (hu) (S)-N-Etil-3-[1-(dimetil-amino)-etil]-N-metil-fenil-karbamátot és antioxidánst tartalmazó gyógyszerkészítmény
ATE309798T1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
DE69803360D1 (de) Anwendungsformen zur behandlung der männlichen erektilen dysfunktion
HUP0303082A2 (hu) Szubsztituált indolil-oxo-acetil-piperazinszármazékok, ezeket tartalmazó készítmények és vírusellenes alkalmazásuk
DK1341524T3 (da) Farmaceutisk præparat i form af en pasta omfattende en syre-labil aktiv bestanddel
ATE375149T1 (de) Behandlung von entzug
DE60229440D1 (de) Zusammensetzung von artenusat und mefloquin zur behandlung von malaria
RU2007103306A (ru) Композиции на основе ризедроната и способы их применения
DE502007003589D1 (de) Verwendung einer kombination von morphin und mindestens einem opiatantagonisten zur behandlung von opiatabhängigkeit und zur verhinderung des nicht-oralen opiatmissbrauchs bei opiatsüchtigen
DE69534177D1 (de) Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung zur Behandlung von Malaria
WO2005023304A3 (en) Antimalarial compositions and manufacturing process thereof
NZ535611A (en) Pharmaceutical composition of a PDE4 or a PDE3/4 inhibitor and a histamine receptor antagonist
MXPA04001912A (es) Aminobenzofenonas novedosas.
DE50000864D1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
DE69329336D1 (de) Acridin carboxamide zur behandlung von krebs
WO2005030197A1 (en) Compound artemisinin
DE60036382D1 (de) Verfahren zur verabreichung von arzneimitteln mit bindungsaffinität zum plasmaprotein und verwendung der zusammensetzung in dem verfahren
JPH01311026A (ja) 薬剤耐性原生動物の感染処置における芳香族三環式化合物類のｎ―アルキルアミノ誘導体類
ATE244010T1 (de) Arzneistoffkombination zur behandlung von kopfschmerzen mit mirtazapine und paracetamol oder nicht-steroiden entzündungshemmenden mitteln
MXPA02011883A (es) Un estuche de combinacion usado en el tratameinto de paludismo que contiene cloroquina y 3-(1-((4 -((6-metoxi-8 -quinolinil)amino) pentil) amino) -etilideno) -dihidro-2(3h) furanona.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties